283 results on '"Wojakowski, Wojtek"'
Search Results
2. TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationale
3. Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3
4. Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement
5. 1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: The HighLife TSMVR Feasibility Study
6. Social disparities in cardiovascular mortality of patients with cancer in the USA between 1999 and 2019
7. Asymptomatic Severe and Moderate Aortic Stenosis: Time for Appraisal of Treatment Indications
8. Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trial
9. Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation
10. Infective Endocarditis Caused by Staphylococcus aureus After Transcatheter Aortic Valve Replacement
11. Global position paper on cardiovascular regenerative medicine
12. Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry
13. Hepatic Fat Changes with Antisense Oligonucleotide Therapy Targeting ANGPTL3
14. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion
15. Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry
16. Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement
17. International evaluation of an artificial intelligence-powered ecg model detecting acute coronary occlusion myocardial infarction
18. Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure
19. TCT-93 Association Between Post-PCI vFFR and OCT Findings: Results From the FAST OCT Study
20. TCT-596 Sex Differences in Use of Fractional Flow Reserve in Patients Undergoing Coronary Angiography and Percutaneous Coronary Intervention
21. TCT-490 Sex-Specific Temporal Trends in Incidence and Outcomes of Cardiogenic Shock in Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention
22. TCT-140 Combined Coexistence of Multiple Vulnerable Plaque Features is Associated With Incremental Rates of Adverse Events in Patients With Diabetes Mellitus: New Insights From the COMBINE OCT-FFR Trial
23. Routine use of procedural sedation and analgesia for transcatheter edge-to-edge mitral valve repair
24. Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement
25. Guía ESC/EACTS 2021 sobre el diagnóstico y tratamiento de las valvulopatías: Desarrollada por el Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) y la European Association for Cardio-Thoracic Surgery (EACTS) sobre el diagnóstico y tratamiento de las valvulopatías
26. Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry
27. INTERNATIONAL EVALUATION OF AN ARTIFICIAL INTELLIGENCE-POWERED ECG MODEL DETECTING OCCLUSION MYOCARDIAL INFARCTION
28. Outcomes of ST elevation myocardial infarction in patients with cancer; a nationwide study
29. Patterns of Aortic Valve Replacement in Europe: Adoption by Age.
30. Computed tomography angiography for guiding and follow-up of magnesium-bioresorbable scaffold implantation
31. Impact of Enterococci vs. Staphylococci Induced Infective Endocarditis after Transcatheter Aortic Valve Implantation
32. Incidence, Clinical Characteristics, and Impact of Absent Echocardiographic Signs in Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation
33. TCT-311 Complicated Plaques Prevail in Longer Lesions of DM Patients, but Lesions’ Length Does Not Impact DM Patients’ Prognosis: Data From COMBINE OCT-FFR Trial
34. TCT-370 Negative Compared to Positive Echocardiographic Imaging of Infective Endocarditis After Transcatheter Aortic Valve Implantation
35. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC)
36. Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease
37. Erratum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease
38. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion
39. Prosthesis-patient mismatch following transcatheter aortic valve replacement for degenerated transcatheter aortic valves: the TRANSIT-PPM international project
40. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
41. Paravalvular Leak Echo Imaging before and during the Percutaneous Procedure
42. The effect of intracoronary infusion of bone marrow‐derived mononuclear cells on all‐cause mortality in acute myocardial infarction: rationale and design of the BAMI trial
43. Effect of allogeneic adipose tissue‐derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction – the SCIENCE trial.
44. Incidence, Clinical Characteristics, and Impact of Absent Echocardiographic Signs in Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation.
45. Effect of Vupanorsen on Non–High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70
46. Safety, Efficacy and Long-Term Outcomes of Patients Treated with the Occlutech Paravalvular Leak Device for Significant Paravalvular Regurgitation
47. Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial
48. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
49. 2021 ESC/EACTS Guidelines for the management of valvular heart disease
50. Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.